| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 04/16/2003 | EP1301126A1 Extended organic cobalt and nickel magnetic complexes |
| 04/16/2003 | EP1083936B1 Diagnostic method and diagnostic means used in carrying out said method |
| 04/16/2003 | EP0991429B1 Use of acousto-optical and sonoluminescence contrast agents in diagnostic methods |
| 04/16/2003 | EP0968173B1 Process for the preparation of iodinated contrast agents and intermediates therefor |
| 04/16/2003 | EP0885016B1 Thermally stabilized contrast agent |
| 04/16/2003 | EP0877631B1 Conjugate of albumin and a xanthen dye for differentiating between diseased and healthy tissues |
| 04/16/2003 | EP0769958B1 Inhibitors of leukocyte adhesion |
| 04/15/2003 | US6548733 Function-based small molecular weight compound screening system in drosophila melanogaster |
| 04/15/2003 | US6548663 Benzodiazepine vitronectin receptor antagonist pharmaceuticals |
| 04/15/2003 | US6548264 Plurality of nanoparticles having a mean size of less than 1 micron, comprising a core containing an inorganic salt pigment and a silica shell enveloping the core |
| 04/15/2003 | US6548171 Fluorescent nanocrystal-embedded microspheres for fluorescence analyses |
| 04/15/2003 | US6548048 Encapsulation gases; medical diagnosis, therapy |
| 04/15/2003 | US6548047 Thermal preactivation of gaseous precursor filled compositions |
| 04/15/2003 | US6548046 Lipid encapsulated particles |
| 04/15/2003 | US6548045 Anticancer agents |
| 04/15/2003 | US6548044 Imaging sexual response |
| 04/15/2003 | US6548043 Test meal kit |
| 04/10/2003 | WO2003029488A2 A method for the early detection of cancer |
| 04/10/2003 | WO2003029482A2 Diagnosing, treating, and preventing cancer using cables |
| 04/10/2003 | WO2003028769A1 Diagnostic reagent for nuclear magnetic resonance imagination |
| 04/10/2003 | WO2003028633A2 Parenteral delivery systems |
| 04/10/2003 | WO2003028527A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/10/2003 | WO2003028446A2 An invertebrate animal model with alzheimer-like pathology for screening and testing molecules |
| 04/10/2003 | WO2003004062A9 Pharmaceutical formulations and ligands for use therein; mimetics for uea-1 |
| 04/10/2003 | WO2002083105A3 Composition for enhanced absorption of nsaids |
| 04/10/2003 | WO2002043767A8 Improved oral delivery of peptides using enzyme-cleavable membrane translocators |
| 04/10/2003 | WO2002008396A3 Human proteases |
| 04/10/2003 | US20030069482 Sampling article for determining quantitative and qualitative drug transfer to skin |
| 04/10/2003 | US20030069264 Method of determining and reducing the risk of bph-related urologic events |
| 04/10/2003 | US20030068362 Methods and formulations for the delivery of pharmacologically active agents |
| 04/10/2003 | US20030068275 Fluorescence detectors; quantitative analaysis |
| 04/10/2003 | US20030068272 Preparation for determining pyrimidine metabolic capacity |
| 04/10/2003 | CA2461099A1 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/10/2003 | CA2460770A1 Diagnosing, treating, and preventing cancer using cables |
| 04/10/2003 | CA2438330A1 A method for the early detection of cancer |
| 04/09/2003 | EP1299718A1 Radio-opaque polymeric compositions |
| 04/09/2003 | EP1299546A2 Aminoacyl trna synthetases |
| 04/09/2003 | EP1299412A2 Protein modification and maintenance molecules |
| 04/09/2003 | EP1073477A4 Methods for detecting lesions in dense breast tissue using lhrh antagonists |
| 04/09/2003 | EP0779933B1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| 04/09/2003 | EP0768898B1 Cascade-polymer complexes and methods of producing the same |
| 04/09/2003 | EP0620012B1 Double contrast x-ray contrast medium for examining large and small intestines |
| 04/09/2003 | CN1408814A Novel light storage luminous material and its use |
| 04/09/2003 | CN1104911C Improvements in or relating to contrast agents |
| 04/08/2003 | US6544496 Diagnostic and contrast agent |
| 04/08/2003 | US6544191 Process for determining the functional residual capacity of the lungs |
| 04/08/2003 | US6543236 Hyperpolarized noble gas extraction methods, masking methods, and associated transport containers |
| 04/08/2003 | CA2184584C Vascular endothelial growth factor 2 |
| 04/08/2003 | CA2127470C Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis |
| 04/03/2003 | WO2003027228A2 Receptors and membrane-associated proteins |
| 04/03/2003 | WO2003026702A1 Particulate imaging contrast agents |
| 04/03/2003 | WO2003026401A2 Kv3.3b POTASSIUM CHANNEL DISRUPTIONS, COMPOSITIONS AND METHODS RELATED THERETO |
| 04/03/2003 | WO2002060524A3 Enhanced ultrasound detection with temperature dependent contrast agents |
| 04/03/2003 | WO2002031492A1 Two-dimensionally quantified image method for distinguishing and quantifying overgrowing tissue or the like |
| 04/03/2003 | WO2002026267A3 Manganes complexes for magnetic resonance imaging |
| 04/03/2003 | WO2002025270A9 Screening systems and methods for identifying modulators of xenobiotic metabolism |
| 04/03/2003 | WO2002014369A9 Human kininogen d5 domain polypeptides and their use |
| 04/03/2003 | US20030066097 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's Disease |
| 04/03/2003 | US20030066096 Comprises encapsulated green fluorescent protein, blue fluorescent protein, and/or phycobiliprotein; for use in toys, paints, slimy play material, textiles (clothing), bubbles, ballons, cosmetics, bath powders, lotions, and foods |
| 04/03/2003 | US20030066095 Wherein linkage between proteins (aequorin and green fluorescent protein (GFP)) stabilizes the system and allow energy transfer via chemiluminescence resonance energy transfer |
| 04/03/2003 | US20030065277 Method and apparatus for measuring factors in mammary fluids |
| 04/03/2003 | US20030065029 Agent for diagnosing and treating malignant tumors |
| 04/03/2003 | US20030064934 Concurrent administering of druh and hypotonic sugar solution |
| 04/03/2003 | US20030064378 Compositions and methods relating to lung specific genes and proteins |
| 04/03/2003 | US20030064030 Ultrasound contrast agents and methods of making and using them |
| 04/03/2003 | US20030064029 Use of a bioactive agent in manufacture of a medicament for pulmonary delivery whereby medicament comprises perforated microstructures which are aerosolized using an inhalation device to provide aerosolized medicament |
| 04/03/2003 | US20030064027 Administering contrast agent comprising stabilized microbubbles which comprises physiologically acceptable gas selected from freons, halogenated hydrocarbons, and fluorinated gases and surfactant; ultrasonically imaging |
| 04/03/2003 | US20030064026 Use of metal complexes that have a plasma protein bond as imaging diagnostic agents for locating an Infarction or a necrosis using lasting positive visualization |
| 04/03/2003 | US20030064025 Imaging systems for in vivo protocols |
| 04/03/2003 | CA2453985A1 Receptors and membrane-associated proteins |
| 04/03/2003 | CA2424813A1 Two-dimensional quantified imaging method for distinguishing and quantifying poliferating tissue from oncogenic heterometaplasia |
| 04/02/2003 | EP1298436A2 Beta-amyloid peptide (BAP) release inhibitor compounds for treating BAP-related diseases and methods for their identification |
| 04/02/2003 | EP1297142A2 Dual specificity antibodies and methods of making and using |
| 04/02/2003 | EP1297014A2 Transporters and ion channels |
| 04/02/2003 | EP1297002A2 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 04/02/2003 | EP1165087A4 In vivo stain compounds and methods of use to identify dysplastic tissue |
| 04/02/2003 | EP0738157B1 Contrast media for x-ray and magnetic resonance imaging |
| 04/02/2003 | EP0717639B1 Polyamino paramagnetic chelates which contain both phosphonate and non-phosphonate moieties for mri |
| 04/02/2003 | EP0696326B1 Use of NDV in the manufacture of a medicament for treating cancer |
| 04/01/2003 | US6541623 Sepsis shock therapy; rheumatic diseases; antiinflammatory agents; nucleotide sequence detector |
| 04/01/2003 | US6541224 Protein for use in treatment, diagnosis and prevention of autoimmune disease |
| 04/01/2003 | US6540981 Light imaging contrast agents |
| 04/01/2003 | US6540980 Method of detecting endometriosis |
| 04/01/2003 | US6540979 Methods for detecting lesions in dense breast tissue using LHRH antagonists |
| 04/01/2003 | US6540978 Inhibitors of the bitter taste response |
| 04/01/2003 | US6540684 Ultrasonic perfusion measurement using contrast agents |
| 04/01/2003 | CA2098570C Vascular catheter having low-profile distal end |
| 03/27/2003 | WO2003025542A2 Immune response associated proteins |
| 03/27/2003 | WO2003025131A2 Protein modification and maintenance molecules |
| 03/27/2003 | WO2003025129A2 Neurotransmission-associated proteins |
| 03/27/2003 | WO2003024940A1 Bifunctional chelating agent for actinium |
| 03/27/2003 | WO2002086449A3 Systems, methods and devices for in vivo monitoring of a localized response via a radiolabeled analyte in a subject |
| 03/27/2003 | WO2002055544A3 Fibrin binding polypeptides useful inter alia in medical imaging processes |
| 03/27/2003 | WO2002047680A3 Use of tocopherol, metabolites or derivatives thereof or flavonoid metabolites or derivatives thereof in the manufacture of a medicament for the treatment of tissue ischemia |
| 03/27/2003 | WO2002043806A3 In vivo delivery methods and compositions |
| 03/27/2003 | US20030060719 Use of 5-aminolevulinic acid or a derivate thereof for photodynamic diagnosis and /or photodynamic therapy |
| 03/27/2003 | US20030060718 Indocyanine green (ICG) compositions and related methods of use |
| 03/27/2003 | US20030060695 Implantable artificial organ devices |
| 03/27/2003 | US20030059937 Antibodies that immunospecifically bind BLyS |
| 03/27/2003 | US20030059854 Detecting modulators of enzyme activity; obtain sample containing preferential kinase, incubate with modulator, monitor adjustment in phosphorylation, adjustment in phosphorylation indicates modulator |